DK1603532T3 - Subkutant afgivelsessystem, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af cholinerge mangellidelser - Google Patents
Subkutant afgivelsessystem, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af cholinerge mangellidelserInfo
- Publication number
- DK1603532T3 DK1603532T3 DK04720662T DK04720662T DK1603532T3 DK 1603532 T3 DK1603532 T3 DK 1603532T3 DK 04720662 T DK04720662 T DK 04720662T DK 04720662 T DK04720662 T DK 04720662T DK 1603532 T3 DK1603532 T3 DK 1603532T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- group
- delivery system
- treatment
- subcutaneous delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
- Percussion Or Vibration Massage (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB0300942 | 2003-03-14 | ||
| IB0304945 | 2003-11-05 | ||
| PCT/IB2004/000734 WO2004080436A1 (en) | 2003-03-14 | 2004-03-15 | Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1603532T3 true DK1603532T3 (da) | 2008-12-08 |
Family
ID=32992641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04720662T DK1603532T3 (da) | 2003-03-14 | 2004-03-15 | Subkutant afgivelsessystem, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af cholinerge mangellidelser |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20070059369A1 (de) |
| EP (2) | EP1603532B1 (de) |
| JP (1) | JP2006520378A (de) |
| KR (1) | KR20060023111A (de) |
| AT (1) | ATE404170T1 (de) |
| AU (1) | AU2004218896B2 (de) |
| BR (1) | BRPI0407818A (de) |
| CA (1) | CA2518883A1 (de) |
| CY (1) | CY1108482T1 (de) |
| DE (1) | DE602004015744D1 (de) |
| DK (1) | DK1603532T3 (de) |
| EA (1) | EA011169B1 (de) |
| ES (1) | ES2312981T3 (de) |
| HK (1) | HK1089085A1 (de) |
| IL (1) | IL170759A (de) |
| IS (1) | IS8067A (de) |
| MX (1) | MXPA05009626A (de) |
| NO (1) | NO20054258L (de) |
| NZ (1) | NZ542459A (de) |
| PL (1) | PL1603532T3 (de) |
| PT (1) | PT1603532E (de) |
| SI (1) | SI1603532T1 (de) |
| UA (1) | UA82226C2 (de) |
| WO (1) | WO2004080436A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006078320A2 (en) | 2004-08-04 | 2006-07-27 | Brookwood Pharmaceuticals, Inc. | Methods for manufacturing delivery devices and devices thereof |
| US8124601B2 (en) * | 2007-11-21 | 2012-02-28 | Bristol-Myers Squibb Company | Compounds for the treatment of Hepatitis C |
| JP5502751B2 (ja) | 2007-12-20 | 2014-05-28 | エボニック コーポレイション | 低残留溶媒濃度を有する微粒子を調製するためのプロセス |
| US8956636B2 (en) * | 2008-04-18 | 2015-02-17 | Warsaw Orthopedic, Inc. | Methods and compositions for treating postoperative pain comprosing ketorolac |
| EP2560623A1 (de) | 2010-04-22 | 2013-02-27 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Orale retard-formulierung von huperzin a |
| WO2013173096A2 (en) * | 2012-05-18 | 2013-11-21 | Insero Health Inc. | Conjugates of huperzine and analogs thereof |
| KR101811797B1 (ko) * | 2013-04-03 | 2017-12-22 | 동국제약 주식회사 | 도네페질을 포함하는 비경구투여용 약제학적 조성물 |
| CN111246849A (zh) * | 2017-10-19 | 2020-06-05 | 株式会社佐藤园 | 学习记忆能力增强组合物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5106979A (en) * | 1989-02-21 | 1992-04-21 | University Of Pittsburgh | Method for the synthesis of huperzine A and analogs thereof and compounds useful therein |
| CN1125725A (zh) | 1994-12-28 | 1996-07-03 | 中国科学院上海药物研究所 | 一类海克林碱衍生物及它的用途 |
| FR2756493B1 (fr) * | 1996-12-02 | 2001-04-13 | Delab | Dispositif d'administration locale de formulations solides ou semi-solides |
| US6352715B1 (en) | 1998-02-19 | 2002-03-05 | Sagittarius Life Science Corp | Transdermal rate-controlled delivery of Huperzine A for treatment of alzheimer's disease |
| US6565874B1 (en) * | 1998-10-28 | 2003-05-20 | Atrix Laboratories | Polymeric delivery formulations of leuprolide with improved efficacy |
| CN1279065A (zh) | 1999-07-06 | 2001-01-10 | 青岛科达生物工程有限公司 | 一种治疗记忆障碍和老年痴呆的药物组合物 |
| CN1194688C (zh) | 2001-07-03 | 2005-03-30 | 山东绿叶制药股份有限公司 | 石杉碱甲及其衍生物或其盐的注射用缓释微球及其制备方法 |
| CN1383824A (zh) | 2002-05-21 | 2002-12-11 | 浙江省医学科学院 | 石杉碱鼻腔给药制剂 |
-
2004
- 2004-03-15 EP EP04720662A patent/EP1603532B1/de not_active Expired - Lifetime
- 2004-03-15 MX MXPA05009626A patent/MXPA05009626A/es active IP Right Grant
- 2004-03-15 DK DK04720662T patent/DK1603532T3/da active
- 2004-03-15 US US10/549,167 patent/US20070059369A1/en not_active Abandoned
- 2004-03-15 DE DE602004015744T patent/DE602004015744D1/de not_active Expired - Lifetime
- 2004-03-15 CA CA002518883A patent/CA2518883A1/en not_active Abandoned
- 2004-03-15 AU AU2004218896A patent/AU2004218896B2/en not_active Ceased
- 2004-03-15 EP EP08159962A patent/EP1977735A1/de not_active Withdrawn
- 2004-03-15 NZ NZ542459A patent/NZ542459A/en unknown
- 2004-03-15 SI SI200430920T patent/SI1603532T1/sl unknown
- 2004-03-15 AT AT04720662T patent/ATE404170T1/de not_active IP Right Cessation
- 2004-03-15 PT PT04720662T patent/PT1603532E/pt unknown
- 2004-03-15 JP JP2006506340A patent/JP2006520378A/ja active Pending
- 2004-03-15 EA EA200501433A patent/EA011169B1/ru not_active IP Right Cessation
- 2004-03-15 ES ES04720662T patent/ES2312981T3/es not_active Expired - Lifetime
- 2004-03-15 WO PCT/IB2004/000734 patent/WO2004080436A1/en active IP Right Grant
- 2004-03-15 PL PL04720662T patent/PL1603532T3/pl unknown
- 2004-03-15 BR BRPI0407818-7A patent/BRPI0407818A/pt not_active IP Right Cessation
- 2004-03-15 KR KR1020057016999A patent/KR20060023111A/ko not_active Application Discontinuation
- 2004-03-15 UA UAA200509681A patent/UA82226C2/uk unknown
-
2005
- 2005-09-08 IL IL170759A patent/IL170759A/en not_active IP Right Cessation
- 2005-09-15 NO NO20054258A patent/NO20054258L/no not_active Application Discontinuation
- 2005-10-11 IS IS8067A patent/IS8067A/is unknown
-
2006
- 2006-08-25 HK HK06109458.0A patent/HK1089085A1/xx not_active IP Right Cessation
-
2008
- 2008-11-06 CY CY20081101257T patent/CY1108482T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IS8067A (is) | 2005-10-11 |
| CY1108482T1 (el) | 2014-04-09 |
| EP1603532B1 (de) | 2008-08-13 |
| ES2312981T3 (es) | 2009-03-01 |
| KR20060023111A (ko) | 2006-03-13 |
| ATE404170T1 (de) | 2008-08-15 |
| PT1603532E (pt) | 2008-11-20 |
| AU2004218896B2 (en) | 2010-04-01 |
| BRPI0407818A (pt) | 2006-02-14 |
| AU2004218896A1 (en) | 2004-09-23 |
| SI1603532T1 (sl) | 2009-02-28 |
| EA200501433A1 (ru) | 2006-02-24 |
| EP1977735A1 (de) | 2008-10-08 |
| MXPA05009626A (es) | 2005-10-18 |
| CA2518883A1 (en) | 2004-09-23 |
| NO20054258L (no) | 2005-11-24 |
| IL170759A (en) | 2010-06-16 |
| DE602004015744D1 (de) | 2008-09-25 |
| US20070059369A1 (en) | 2007-03-15 |
| HK1089085A1 (en) | 2006-11-24 |
| NO20054258D0 (no) | 2005-09-15 |
| JP2006520378A (ja) | 2006-09-07 |
| UA82226C2 (uk) | 2008-03-25 |
| EP1603532A1 (de) | 2005-12-14 |
| NZ542459A (en) | 2008-12-24 |
| EA011169B1 (ru) | 2009-02-27 |
| WO2004080436A1 (en) | 2004-09-23 |
| PL1603532T3 (pl) | 2009-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108482T1 (el) | Συστημα υποδοριας διανομης, μεθοδος παρασκευης του και χρηση του για την αγωγη διαταραχων xολινεργικης ανεπαρκειας | |
| BG108225A (en) | Thiohydantoins and use thereof for treating diabetes | |
| BR0215429A (pt) | Composto de fórmula i e seus usos, métodos de inibição da atividade e método de inibição da ativação de um receptor de monoamina, métodos de tratamento, método de identificação de polimorfismo genético e método de identificação de paciente | |
| CY1107452T1 (el) | Διαδερμικη μορφη χορηγησης για τη θεραπεια του συνδρομου ανησυχων ποδιων | |
| CO5180642A1 (es) | Compuestos sustituidos de piperidina, procesos para su prepa racion, composiciones farmaceuticas que los contienen y su utilizacion | |
| HK1080764A1 (en) | Implant for transport and release for pharmacologically active agents as well as a process for producing the same | |
| TR200302214T4 (tr) | Psoriasis tedavisi için kullanilan pteridine bileşkenleri | |
| BRPI0410669A (pt) | inibidores de caspase e usos dos mesmo | |
| NO20020282L (no) | Nytt difenyl-piperidinderivat | |
| DE69819110D1 (de) | Ein Arzneimittel zur Behandlung von Fettleibigkeit und Verbesserung des lipidmetabolismus | |
| NO20041060L (no) | Krystaller av hydroksynorefedrinderivat | |
| UA90504C2 (ru) | Лекарственное средство для лечения заболеваний дыхательных путей | |
| ATE554753T1 (de) | 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia | |
| GB2446341A (en) | Method and system for transdermal drug delivery | |
| NO20054034L (no) | Fremgangsmate for behandling av hypotyroidisme. | |
| HUP0000110A2 (hu) | Azaciklusos, azabiciklusos vagy tetrahidropiridinszármazékokat tartalmazó, fájdalom kezelésére alkalmas gyógyászati készítmények | |
| NO20055254D0 (no) | Farmasoytisk kombinasjon for behandling av spastisitet og/eller smerte | |
| DK1353660T3 (da) | Anvendelse af substituerede 6-dimethylaminomethyl-1-phenylcyclohexanforbindelser til behandling af urininkontinens | |
| BR0014447A (pt) | Derivados de piperidina como inibidores da reabsorção | |
| BR0212466A (pt) | Administração sistemática de algumas oxazolidinonas, por exemplo linezolida, tratamento para infecções oculares | |
| DE69901716T2 (de) | Pharmazeutische zusammensetzung enthaltend factor xiiia für nervenheilung | |
| IS6416A (is) | Fjórgild ammóníum og notkun þeirra sem miðlar gegn hósta |